Trials / Completed
CompletedNCT00000302
Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
Expanded Steady-State Pharmacokinetic Study, Comparing Liquid and Tablet Buprenorphine Formulations
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 21 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare liquid and tablet buprenorphine formulations.
Detailed description
Participants were inducted on either liquid or tablet buprenorphine, in a double-blind, double-dummy manner. They each reached a steady state by the second week, and were scheduled to have blood draws in weeks 3, 4, 7, 8, 11, 12, 15, and 16.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Buprenorphine |
Timeline
- First posted
- 1999-09-21
- Last updated
- 2005-11-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000302. Inclusion in this directory is not an endorsement.